1. Home
  2. XCUR vs KZR Comparison

XCUR vs KZR Comparison

Compare XCUR & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XCUR
  • KZR
  • Stock Information
  • Founded
  • XCUR 2011
  • KZR 2015
  • Country
  • XCUR United States
  • KZR United States
  • Employees
  • XCUR N/A
  • KZR N/A
  • Industry
  • XCUR Biotechnology: Pharmaceutical Preparations
  • KZR Biotechnology: Pharmaceutical Preparations
  • Sector
  • XCUR Health Care
  • KZR Health Care
  • Exchange
  • XCUR Nasdaq
  • KZR Nasdaq
  • Market Cap
  • XCUR 32.4M
  • KZR 29.7M
  • IPO Year
  • XCUR N/A
  • KZR 2018
  • Fundamental
  • Price
  • XCUR $3.88
  • KZR $3.95
  • Analyst Decision
  • XCUR
  • KZR Hold
  • Analyst Count
  • XCUR 0
  • KZR 2
  • Target Price
  • XCUR N/A
  • KZR $9.00
  • AVG Volume (30 Days)
  • XCUR 27.1K
  • KZR 35.9K
  • Earning Date
  • XCUR 11-13-2025
  • KZR 11-11-2025
  • Dividend Yield
  • XCUR N/A
  • KZR N/A
  • EPS Growth
  • XCUR N/A
  • KZR N/A
  • EPS
  • XCUR N/A
  • KZR N/A
  • Revenue
  • XCUR N/A
  • KZR N/A
  • Revenue This Year
  • XCUR N/A
  • KZR N/A
  • Revenue Next Year
  • XCUR N/A
  • KZR N/A
  • P/E Ratio
  • XCUR N/A
  • KZR N/A
  • Revenue Growth
  • XCUR N/A
  • KZR N/A
  • 52 Week Low
  • XCUR $1.44
  • KZR $3.62
  • 52 Week High
  • XCUR $36.00
  • KZR $9.18
  • Technical
  • Relative Strength Index (RSI)
  • XCUR 23.53
  • KZR 46.17
  • Support Level
  • XCUR $3.10
  • KZR $3.76
  • Resistance Level
  • XCUR $7.06
  • KZR $4.09
  • Average True Range (ATR)
  • XCUR 0.38
  • KZR 0.14
  • MACD
  • XCUR -0.15
  • KZR 0.02
  • Stochastic Oscillator
  • XCUR 25.06
  • KZR 42.22

About XCUR Exicure Inc.

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

About KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Share on Social Networks: